Symdeko
My Prescription
Payment
Select pharmacy
$26,278.89
Print or send this coupon to your phone
AlbertsonsPowered byAbout Symdeko
Drug Details
Symdeko is a medication designed to treat cystic fibrosis in individuals aged 6 years and older who have specific mutations in the CFTR gene. It is composed of two active ingredients: tezacaftor and ivacaftor. These drugs work together to improve the function of the CFTR protein, helping to enhance breathing, reduce the likelihood of lung infections, and support weight gain. Symdeko is particularly intended for patients with two copies of the F508del mutation or at least one mutation responsive to this treatment. Ensure to consult with a healthcare professional for advice tailored to your health needs.
Price history for Symdeko
56 Tablet Therapy Packs, 100-150 & 150MG
Average retail price for Symdeko
Average SaveHealth price for Symdeko
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Symdeko dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 50-75 & 75MG | 56 Tablet Therapy Packs | $26,278.89 | $469.27 |
| 100-150 & 150MG | 56 Tablet Therapy Packs | $26,278.89 | $469.27 |
Symdeko FAQs
Symdeko is used for the treatment of cystic fibrosis in patients who have specific mutations in the CFTR gene. It is typically prescribed for patients aged 6 years and older. Symdeko works by improving the function of the defective protein made by the CFTR gene, thereby helping to manage the symptoms of cystic fibrosis.
Symdeko and Trikafta are both medications used to treat cystic fibrosis, but they differ in their composition and the range of mutations they target. Symdeko is a combination of two drugs, tezacaftor and ivacaftor, and is typically prescribed for patients with specific mutations in the CFTR gene. Trikafta, on the other hand, is a combination of three drugs: elexacaftor, tezacaftor, and ivacaftor. Trikafta is designed to treat a broader range of CFTR mutations, including the most common F508del mutation, and is often prescribed for patients who may not respond to other treatments.
Symkevi and Symdeko are essentially the same medication, known by different names in different regions. Symkevi is the brand name used in Europe, while Symdeko is the brand name used in the United States. Both contain the active ingredients tezacaftor and ivacaftor, and are used in the treatment of cystic fibrosis in patients with specific genetic mutations.
The cost of Symdeko can vary depending on factors such as insurance coverage, pharmacy, and location. Without insurance, the price can be quite high, often exceeding several thousand dollars per month. It is recommended to check with a pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may explore patient assistance programs offered by the manufacturer to help reduce costs.
Symdeko contains two active ingredients: tezacaftor and ivacaftor. Additionally, it includes several inactive ingredients such as microcrystalline cellulose, croscarmellose sodium, hypromellose acetate succinate, sodium lauryl sulfate, magnesium stearate, and others that may vary depending on the formulation.